Skip to content


Making Inhaled Therapies Fit for the Future



Broughton has been featured in an article on ‘Making Inhaled Therapies Fit for the Future: Improving the Sustainability of Pressurised Metered Dose Inhalers’ for Innovations in Pharmaceutical Technology magazine.

The article investigates how pressured metered dose inhalers (pMDIs) have become the most popular treatment choice for patients suffering from common respiratory diseases such as asthma, despite pMDIs accounting for 3.9% of the NHS’s annual carbon emissions. Andrew looks at what options are available to improve the sustainability of the device in the future. You can read the full article here -